Glucose Baxter (Glucose Monohydrate)

Glucose Baxter is indicated for several clinical situations where rapid glucose delivery or fluid replacement is required.

• Treatment of hypoglycemia when oral glucose is not feasible.
• Provision of carbohydrate calories in parenteral nutrition regimens.
• Volume expansion in patients with fluid loss or dehydration.
• Electrolyte and fluid balance support during surgery or critical care.
• Adjunct therapy for patients receiving intravenous medications that may cause hypoglycemia.

Adverse reactions to Glucose Baxter are generally related to its composition and route of administration.

Common

• Mild hyperglycemia or transient elevation of blood glucose.
• Local irritation or phlebitis at the infusion site.
• Nausea or mild gastrointestinal discomfort.
• Electrolyte shifts, particularly mild potassium changes.

Serious

• Severe hyperglycemia requiring medical intervention.
• Anaphylactic or severe allergic reaction.
• Volume overload leading to pulmonary edema.
• Hyperosmolar state with neurological symptoms.
• Metabolic acidosis in susceptible patients.

When using Glucose Baxter, clinicians should consider several safety precautions to minimize risks.

• Monitor blood glucose levels before, during, and after infusion.
• Assess patient fluid status and avoid rapid infusion in heart failure.
• Use aseptic technique to prevent contamination.
• Adjust infusion rate in patients with renal impairment.
• Verify compatibility with other IV solutions before mixing.
• Avoid use in patients with known hypersensitivity to glucose monohydrate.
• Document infusion parameters and patient response.

Glucose Baxter may interact with other intravenous agents, influencing efficacy or safety.

Avoid

• Concurrent high‑dose insulin administration without close glucose monitoring.
• Mixing with calcium‑containing solutions, which can cause precipitation.
• Combining with hypertonic saline solutions, increasing osmolar load.

Use with caution

• Concomitant diuretics, which may affect fluid balance.
• Electrolyte supplements, especially potassium, due to potential shifts.
• Other hyperglycemic agents that may exacerbate hyperglycemia.
• Blood products, requiring compatibility checks.
• Vasopressors, as fluid shifts may alter circulatory response.